News from roche A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

25 Sep, 2019, 06:05 BST Roche launches cobas EBV and BKV Tests on the cobas 6800/8800 Systems for transplant patients

- Immunocompromised transplant recipients are at risk of major complications when infected with Epstein-Barr or BK viruses - With the new cobas EBV...


28 May, 2019, 15:03 BST Roche launches first in vitro diagnostic IHC test to detect ROS1 protein in cancers

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the global launch of the VENTANA ROS1 (SP384) Rabbit Monoclonal Primary Antibody, the first and...


21 Mar, 2019, 14:00 GMT Roche launches NAVIFY Mutation Profiler and NAVIFY Therapy Matcher to support comprehensive genomic profiling in cancer

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the CE-IVD mark and launch of NAVIFY Mutation Profiler, clinical software that provides...


22 Jan, 2019, 07:05 GMT Infants and people living in remote areas to benefit from new sample types compatible with Roche's HIV test on cobas 4800 System

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the addition of two new sample types for utilization on the cobas® 4800 System: Dried Blood Spot...


15 Jan, 2019, 15:02 GMT Roche launches uPath enterprise software with improved speed, performance and usability for digital pathology

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of its innovative uPath enterprise software[1] for digital pathology. Offering a new...


11 Dec, 2018, 15:05 GMT Roche to develop companion diagnostic test to help identify patients eligible for anti-PD-1 therapy based on biomarker expression, not location, of solid tumors

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it entered into a collaboration with Merck (known as MSD outside the United States and...


27 Nov, 2018, 12:00 GMT Roche launches first IVD pan-TRK immunohistochemistry assay

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the global launch of the VENTANA pan-TRK (EPR17341) Assay, the first automated in vitro diagnostic ...


01 Oct, 2018, 08:00 BST Roche signs collaboration agreement to expand access to therapy information by integrating insulin data from connected pens to its open ecosystem

- Roche accelerates growth of its digital health solutions by building on its successful collaboration with Novo Nordisk. - Under the terms of the...


26 Sep, 2018, 13:00 BST Roche advances its open diabetes management ecosystem by integrating continuous glucose monitoring data to drive personalised therapy decisions

- The expansion of the partnership with Senseonics is the next step in integrating the long-term Eversense® Continuous Glucose Monitoring (CGM)...


25 Jun, 2018, 13:00 BST Roche expands access to the mySugr integrated diabetes management solution in the U.S. and Canada

- Roche strengthens its position in digital health with a strategic partnership and investment in Care Innovations. - The partnership will enable...


26 Mar, 2018, 15:00 BST Roche launches VENTANA DP 200 slide scanner for digital pathology

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the VENTANA DP 200 high-speed slide scanner for digital pathology. Its unique,...


24 Jan, 2018, 06:00 GMT Roche launches cobas TV/MG on the cobas 6800/8800 Systems in markets accepting the CE mark

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the CE-IVD launch of cobas® TV/MG, for use on the cobas 6800/8800 Systems for the direct detection ...


16 Jan, 2018, 17:00 GMT Roche launches CE-marked VENTANA MMR IHC Panel for patients diagnosed with colorectal cancer

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the CE-marked VENTANA MMR IHC Panel, which provides clinicians with a comprehensive...


27 Nov, 2017, 12:30 GMT Roche launches HyperCap Target Enrichment Portfolio, a fully integrated and streamlined NGS sample prep solution for research use

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the launch of the HyperCap Target Enrichment Portfolio, a streamlined and fully integrated NGS...


16 Nov, 2017, 15:00 GMT Roche launches DISCOVERY Teal HRP chromogen detection kit to advance tissue-based cancer research

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the DISCOVERY Teal HRP kit1, the newest addition to the comprehensive collection of...


14 Nov, 2017, 18:00 GMT Roche receives FDA clearance for the VENTANA MMR IHC Panel for patients diagnosed with colorectal cancer

-- The VENTANA MMR IHC Panel1 helps differentiate between sporadic colorectal cancer and probable Lynch syndrome, a hereditary form of colorectal...


07 Nov, 2017, 15:58 GMT Roche receives FDA approval for VENTANA ALK (D5F3) CDx Assay to identify lung cancer patients eligible for treatment with Roche's ALECENSA (alectinib)

- The VENTANA ALK (D5F3) CDx Assay(1) companion diagnostic is now indicated as an aid in identifying lung cancer patients eligible for treatment with ...


28 Sep, 2017, 15:05 BST Roche gains CE label expansion for PD-L1 testing in lung and bladder cancers in markets where TECENTRIQ is approved

-- PD-L1 is a protein involved in the suppression of the immune system, which can impact the body's ability to fight cancer -- The VENTANA PD-L1...


26 Jul, 2017, 13:00 BST Roche launches the AVENIO Millisect System for precise and efficient dissection of tissue biopsies

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the commercial availability of the AVENIO Millisect System, a tissue dissection instrument that...


26 Jul, 2017, 06:00 BST Roche signs collaboration agreement to create core data platform for its digital diabetes ecosystem

- New core data platform will connect all existing and future products, solutions and services to provide users a holistic solution for diabetes...


25 Jul, 2017, 18:30 BST Roche gains CE label expansion for companion diagnostic to identify ALK-positive non-small cell lung cancer patients

Lung cancer remains the leading cause of cancer deaths, with 1.6 million deaths worldwide each year.1 ALK – anaplastic lymphoma kinase – is an...


25 Jul, 2017, 08:00 BST Roche expands Global Access Program to include the first fully automated CE marked nucleic acid HIV-1/HIV-2 qualitative diagnostic test

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the expansion of the Global Access Program to include the cobas® HIV-1/HIV-2 for use on the fully...


04 Jul, 2017, 07:00 BST Roche launches the first fully automated CE marked HIV-1/HIV-2 qualitative diagnostic test on cobas® 6800/8800 Systems

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the commercial availability of the cobas® HIV-1/HIV-2 for use on the automated cobas® 6800/8800...


28 Jun, 2017, 15:30 BST Roche expands Harmony® Prenatal Test to include 22q11.2 deletion testing

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it has added 22q11.2 deletion testing to the menu of the Harmony® Prenatal Test, a...


01 Jun, 2017, 15:05 BST Roche announces FDA approval of companion diagnostic to identify ALK-positive non-small cell lung cancer patients

More than 1.6 million people die globally from lung cancer each year.1 ALK – anaplastic lymphoma kinase – is an important biomarker found in...